148 related articles for article (PubMed ID: 20842140)
1. Circulating tumor cells and melanoma progression.
Xu X; Zhong JF
J Invest Dermatol; 2010 Oct; 130(10):2349-51. PubMed ID: 20842140
[TBL] [Abstract][Full Text] [Related]
2. Circulating melanoma cells as a predictive biomarker.
Karakousis G; Yang R; Xu X
J Invest Dermatol; 2013 Jun; 133(6):1460-2. PubMed ID: 23673501
[TBL] [Abstract][Full Text] [Related]
3. Transcript-Based Detection of Circulating Melanoma Cells.
Morici M; Lin W; Gray ES
Methods Mol Biol; 2021; 2265():235-245. PubMed ID: 33704719
[TBL] [Abstract][Full Text] [Related]
4. Future of circulating tumor cells in the melanoma clinical and research laboratory settings.
De Souza LM; Robertson BM; Robertson GP
Cancer Lett; 2017 Apr; 392():60-70. PubMed ID: 28163189
[TBL] [Abstract][Full Text] [Related]
5. Biomarker utility of circulating tumor cells in metastatic cutaneous melanoma.
Khoja L; Lorigan P; Zhou C; Lancashire M; Booth J; Cummings J; Califano R; Clack G; Hughes A; Dive C
J Invest Dermatol; 2013 Jun; 133(6):1582-90. PubMed ID: 23223143
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and heterogeneity of circulating tumour cells in metastatic cutaneous melanoma.
Khoja L; Shenjere P; Hodgson C; Hodgetts J; Clack G; Hughes A; Lorigan P; Dive C
Melanoma Res; 2014 Feb; 24(1):40-6. PubMed ID: 24201293
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the liquid biopsy for the detection of BRAFV600E mutation in metastatic melanoma patients.
Salvianti F; Massi D; De Giorgi V; Gori A; Pazzagli M; Pinzani P
Cancer Biomark; 2019; 26(3):271-279. PubMed ID: 31524142
[TBL] [Abstract][Full Text] [Related]
8. Orthotopic model for the analysis of melanoma circulating tumor cells.
Pícková M; Kahounová Z; Radaszkiewicz T; Procházková J; Fedr R; Nosková M; Radaszkiewicz KA; Ovesná P; Bryja V; Souček K
Sci Rep; 2024 Apr; 14(1):7827. PubMed ID: 38570556
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of circulating melanoma cells by size filtration and fluorescent in-situ hybridization.
Yanagita M; Luke JJ; Hodi FS; Jänne PA; Paweletz CP
Melanoma Res; 2018 Apr; 28(2):89-95. PubMed ID: 29406397
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumour cells as tumour biomarkers in melanoma: detection methods and clinical relevance.
Khoja L; Lorigan P; Dive C; Keilholz U; Fusi A
Ann Oncol; 2015 Jan; 26(1):33-39. PubMed ID: 24907634
[TBL] [Abstract][Full Text] [Related]
11. Application of a filtration- and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma.
De Giorgi V; Pinzani P; Salvianti F; Panelos J; Paglierani M; Janowska A; Grazzini M; Wechsler J; Orlando C; Santucci M; Lotti T; Pazzagli M; Massi D
J Invest Dermatol; 2010 Oct; 130(10):2440-7. PubMed ID: 20535130
[TBL] [Abstract][Full Text] [Related]
12. Label-free high-throughput photoacoustic tomography of suspected circulating melanoma tumor cells in patients in vivo.
Hai P; Qu Y; Li Y; Zhu L; Shmuylovich L; Cornelius LA; Wang LV
J Biomed Opt; 2020 Mar; 25(3):1-17. PubMed ID: 32170857
[TBL] [Abstract][Full Text] [Related]
13. Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management.
Ireland A; Millward M; Pearce R; Lee M; Ziman M
Clin Exp Metastasis; 2011 Apr; 28(4):327-36. PubMed ID: 21311956
[TBL] [Abstract][Full Text] [Related]
14. High Number of Circulating Tumor Cells Predicts Poor Survival of Cutaneous Melanoma Patients in China.
Li J; Fu W; Zhang W; Li P
Med Sci Monit; 2018 Jan; 24():324-331. PubMed ID: 29337932
[TBL] [Abstract][Full Text] [Related]
15. In vivo ultra-fast photoacoustic flow cytometry of circulating human melanoma cells using near-infrared high-pulse rate lasers.
Nedosekin DA; Sarimollaoglu M; Ye JH; Galanzha EI; Zharov VP
Cytometry A; 2011 Oct; 79(10):825-33. PubMed ID: 21786417
[TBL] [Abstract][Full Text] [Related]
16. Capture and Isolation of Circulating Melanoma Cells Using Photoacoustic Flowmetry.
Edgar RH; Cook J; Douglas M; Samson AP; Viator JA
Methods Mol Biol; 2021; 2265():203-212. PubMed ID: 33704716
[TBL] [Abstract][Full Text] [Related]
17. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
18. Circulating Tumor Cells in Stage IV Melanoma Patients.
Hall CS; Ross M; Bowman Bauldry JB; Upshaw J; Karhade MG; Royal R; Patel S; Lucci A
J Am Coll Surg; 2018 Jul; 227(1):116-124. PubMed ID: 29746918
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of monitoring circulating tumor cells as a therapeutic biomarker in melanoma with BRAF mutation.
Kiniwa Y; Nakamura K; Mikoshiba A; Ashida A; Akiyama Y; Morimoto A; Okuyama R
BMC Cancer; 2021 Mar; 21(1):287. PubMed ID: 33731038
[TBL] [Abstract][Full Text] [Related]
20. Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.
Koyanagi K; O'Day SJ; Gonzalez R; Lewis K; Robinson WA; Amatruda TT; Wang HJ; Elashoff RM; Takeuchi H; Umetani N; Hoon DS
J Clin Oncol; 2005 Nov; 23(31):8057-64. PubMed ID: 16258104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
